Table 3.
Antibiotic susceptibility pattern of ESBL producing Escherichia coli
| Antibiotics | S (%) | I (%) | R (%) |
|---|---|---|---|
| Amikacin | 32 (45.71) | 6 (8.71) | 32 (45.43) |
| Ampicillin | 0 (0.00) | 0 (0.00) | 70 (100.00) |
| Amoxicillin–clavulanic acid | 25 (35.71) | 7 (10.00) | 38 (54.29) |
| Aztreonam | 3 (4.29) | 0 (0.00) | 67 (95.71) |
| Ceftriaxone | 10 (14.29) | 2 (2.86) | 58 (82.86) |
| Cefotaxime | 5 (7.14) | 2 (2.86) | 63 (90.00) |
| Ceftazidime | 7 (10.00) | 2 (2.86) | 61 (87.14) |
| Chloramphenicol | 0 (0.00) | 0 (0.00) | 70 (100.00) |
| Ciprofloxacin | 15 (21.43) | 3 (4.29) | 52 (74.29) |
| Ertapenem | 65 (92.86) | 0 (0.00) | 5 (7.14) |
| Gentamicin | 21 (30.00) | 4 (5.71) | 45 (64.29) |
| Imipenem | 68 (97.14) | 1 (1.43) | 1 (1.43) |
| Meropenem | 65 (92.86) | 1 (1.43) | 4 (4.29) |
| Nitrofurantoin | 39 (55.71) | 4 (5.71) | 27 (38.57) |
| Ofloxacin | 26 (37.14) | 0 (0.00) | 44 (62.86) |
| Piperacillin/tazobactam | 42 (60.00) | 4 (5.71) | 24 (34.29) |
| Tetracycline | 0 (0.00) | 0 (0.00) | 70 (100.00) |
S sensitivity, I intermediate, R resistant